Apnicaf Oral Solution

About this Medicine

Apnicaf Oral Solution is a prescription medicine used in the treatment of apnea (a disorder in which breathing repeatedly stops and starts) of prematurity. It facilitates normal breathing and reduces interrupted breathing in premature newborns. Apnicaf Oral Solution is given under the supervision of healthcare professionals. It is given by mouth or via a gastric feeding tube only. Remember, if you are breastfeeding while your infant is treated with this medicine, then do not drink coffee or take any other high caffeine product as this passes into breast milk.Some common side effects of using this medicine are restlessness, insomnia, headaches, dizziness, increased heart rate. Consult your doctor if these persist for a longer duration or get worse. They may be able to suggest ways to prevent or reduce these side effecrts.

How it Works

Apnicaf Oral Solution is a stimulant. It works by blocking the action of certain natural substances (adenosine and phosphodiesterase) leading to stimulation of the brain and respiratory system in premature newborns. This reduces the number of episodes of interrupted breathing and helps the newborns breathe on their own.

Key Facts

Chemical Class :: Xanthine Derivative|Habit Forming :: No|Therapeutic Class :: CARDIAC|Action Class :: Adenosine receptor (A1 & A2) antagonist

Safety Overview